CNS Pharmaceuticals Inc. (CNSP)
0.10
-0.00 (-3.47%)
At close: Jan 29, 2025, 3:59 PM
0.10
0.00%
After-hours Jan 29, 2025, 07:58 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| PE Ratio | -0.25 | -213.97 | -1.24K | -3.11K | -16.76K | -10.17K | -142.79K |
| PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PB Ratio | -1.07 | 401.85 | 2.70K | 2.11K | 8.55K | -136.85K | -1.28M |
| P/FCF Ratio | -0.34 | -309.42 | -1.32K | -4.00K | -18.18K | -104.93K | -670.00K |
| P/OCF Ratio | -0.34 | -309.55 | -1.32K | -4.01K | -18.28K | -104.93K | -670.00K |
| OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Debt / Equity Ratio | -0.07 | 0.05 | 0.06 | 0.03 | n/a | -0.58 | -2.08 |
| Quick Ratio | 0.26 | 2.55 | 3.50 | 8.13 | 25.38 | 0.48 | 0.73 |
| Current Ratio | 0.26 | 2.55 | 3.50 | 8.13 | 25.38 | 0.48 | 0.73 |
| Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Interest Coverage | n/a | -2.17K | -1.51K | -2.90K | -86.65 | -18.88 | n/a |
| Return on Equity (ROE) | 4.25 | -1.88 | -2.19 | -0.68 | -0.51 | 13.46 | 8.99 |
| Return on Assets (ROA) | -11.08 | -1.17 | -1.66 | -0.6 | -0.49 | -10.82 | -3.25 |
| Return on Capital (ROIC) | 4.26 | -1.88 | -2.12 | -0.68 | -0.5 | 1.61 | 3.67 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a |